For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the introduction of this treatment and Attruby represents a significant advancement . These groundbreaking therapies protect the transthyretin protein, preventing its damaging build-up and lessening